In vitro activity of cefazolin against recent clinical bacterial isolates.
D000362:Agar / Q000494:pharmacology; D000667:Ampicillin / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects*; D002228:Carbenicillin / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology*; D002512:Cephalothin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D007709:Klebsiella / Q000187:drug effects; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009254:Nafcillin / Q000494:pharmacology; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D010068:Oxacillin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D011511:Proteus; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology; D013777:Tetrazoles / Q000494:pharmacology; D013830:Thiadiazoles / Q000494:pharmacology*
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D009254:Nafcillin; D000667:Ampicillin; D000362:Agar; D002228:Carbenicillin; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin; D010068:Oxacillin